4 news items
Evolent Health Sees Q2 Revenue $625M-$645M Vs $606.64M Est.; FY24 Revenue $2.53B-$2.60B Vs $2.47B Est.
EVH
9 May 24
million. In reiterating its Adjusted EBITDA outlook for the year, the company noted growth in its diverse portfolio of risk and non-risk products
Evolent Announces First Quarter 2024 Results
EVH
9 May 24
, the company noted growth in its diverse portfolio of risk and non-risk products and certain contractual protections available to the company in its
In-Depth Examination Of 6 Analyst Recommendations For Evolent Health
EVH
22 Apr 24
months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings
Analyst Scoreboard: 4 Ratings For Evolent Health
EVH
23 Feb 24
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Evolent Health
- Prev
- 1
- Next